COLA MICHAEL F (President and CEO) purchased 938.0% of their position (2.05M shares) of AEVI GENOMIC MEDICINE, LLC on the open market
Open‑market purchase worth $274.6K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/9/2019ACC: 0001192482-19-000513
DirectorOfficer· President and CEO
Since Dec 2019
+2.05M
Net shares
Net buyer
$274.6K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.05M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.05M
Price / share
$0.13
Trade value
$274.62K
% of position
938.0%
12/5/2019
218.48K→2.27M
Total
Net shares
+2.05M
Net value
$274.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/5/2019 | P · Purchase | +2.05M | $0.13 | $274.62K | 938.0% | 218.48K | 2.27M |
| Total | +2.05M | $274.62K | ||||||
Derivative Transactions0
No derivative transactions reported